Simulation guided target discovery for age-linked diseases
Shift Bioscience has raised $16.3M in total funding. The most recent round was Seed. The last funding was announced in October 2024.
Shift Bioscience's investors include Business Growth Fund, Kindred Capital, F-Prime Capital, IKJ Capital, Jonathan Milner.
Shift Bioscience is headquartered in Cambridge, United Kingdom.
Simulation guided target discovery for age-linked diseases
Shift Bioscience is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Shift Bioscience — Funding & Investors." VCBacked, October 15, 2024, https://www.vcbacked.co/company/shift-bioscience. Accessed July 22, 2026.
VCBacked. (2024). Shift Bioscience — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/shift-bioscience
{{cite web |title=Shift Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/shift-bioscience |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated